New drug radiprodil tested for tough seizures in two brain conditions
Disease control
Ongoing
This early-phase trial tests an experimental drug called radiprodil in 30 people with tuberous sclerosis complex or focal cortical dysplasia type II whose seizures have not responded to at least two other medications. The study is open-label, meaning everyone gets the drug, and w…
Phase: PHASE1, PHASE2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC